Characterization of Anti-CCR5 Ribozyme-Transduced CD34+ Hematopoietic Progenitor Cells in Vitro and in a SCID-hu Mouse Model in Vivo
Open Access
- 1 March 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (3) , 244-254
- https://doi.org/10.1006/mthe.2000.0038
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- HIV EPIDEMIOLOGY: On World AIDS Day, a Shadow Looms Over Southern AfricaScience, 1998
- Limitations of a Molecular Clock Applied to Considerations of the Origin of HIV-1Science, 1998
- HIV Survives Drug Onslaught By Hiding Out in T CellsScience, 1997
- CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In VitroThe Journal of Experimental Medicine, 1997
- Expression of Hammerhead Ribozymes by Retroviral Vectors to Inhibit HIV-1 Replication: Comparison of RNA Levels and Viral InhibitionAntisense and Nucleic Acid Drug Development, 1996
- Ribozyme gene therapy for HIV infection Intracellular immunization of lymphocytes and CD34+ cells with an anti-HIV-1 ribozyme geneAdvanced Drug Delivery Reviews, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- The SCID-hu mouse as a model for HIV-1 infectionNature, 1993
- Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells.The Journal of Experimental Medicine, 1991
- The Role of Mononuclear Phagocytes in HTLV-III/LAV InfectionScience, 1986